6:33 PM
 | 
Dec 17, 2012
 |  BC Extra  |  Top Story

Vivalis to merge with Intercell

Vivalis S.A. (Euronext:VLS) will merge with infectious disease company Intercell AG (VSE:ICLL; OTCQX:INRLY) in a stock deal that values Intercell at about EUR 132.5 million ($174.4 million). The combined company, which will be a public company named Valneva SE, will also raise EUR 40 million ($52.6 million) in a fully committed rights issue following the close of the merger,...

Read the full 282 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >